Testing effectiveness (Phase 2)Ended earlyNCT02346422
What this trial is testing
High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
Who this might be right for
Ischemic CardiomyopathyNon-ischemic CardiomyopathyHeart Failure+1 more
Celladon Corporation 9